HOME >> BIOLOGY >> NEWS
Fruit fly research set to revolutionize study of birth defects

KINGSTON, Ont. -- A Queen's University study of fruit flies that may revolutionize the way birth defects are studied has identified the genes affected by a widely-prescribed drug known to cause birth defects.

Methotrexate (MTX), a popular cancer-fighting drug also used to treat psoriasis, ectopic pregnancies, rheumatoid arthritis, and lupus, lasts a long time in the body and causes birth defects in children from women who have it in their systems. The study of the drug's effect on fruit flies has allowed Queen's researchers including graduate student Joslynn Affleck to identify the genes on which the drug acts.

"We hope that through this model system we can provide insight into mammalian birth defects, which may be expected to increase in frequency in the future, due to the recent elevated use of MTX," says Affleck.

Many of the genes found to be affected by MTX are involved in cell cycle regulation, signal transduction, transport, defense response, transcription, or various aspects of metabolism.

"This study shows that MTX treatment has multiple targets," says Affleck. "And this provides us with a novel invertebrate model for the study of drugs that cause birth defects." The findings, funded by NSERC, are set to be published by Toxicological Sciences in the New Year.

"This is not a journal in the habit of publishing insect studies," notes biologist Dr. Virginia Walker, who co-authored the study. "The neat thing about this work is that fruit flies treated with this drug show 'birth defects' that are hauntingly similar to birth defects in human babies. Babies have bent limbs, tufts of hair and bulging eyes and the fruit flies have bent legs (and wings), tufts of bristles and rough eyes."

While identifying this gene array is significant in its own right, the successful use of fruit flies in this kind of study is a revelation to the researchers who view it as an efficient model for the initial testing of "rescue" t
'"/>

Contact: Sarah Withrow
withrows@post.queensu.ca
613-533-3280
Queen's University
21-Nov-2005


Page: 1 2

Related biology news :

1. Fruit fly gene from out of nowhere is discovered
2. Fruit fly research may clean up conventional impressions of biology
3. Fruit bats are not blind as a bat
4. Survival of the rarest: Fruit flies shed light on the evolution of behavior
5. Fruit fly gene research may shed light on human disease processes
6. Fruit flies may pave way to new treatments for age-related heart disease
7. Fruit flies and global warming -- some like it hot
8. Fruit fly dating game provides clues to our reproductive prowess
9. Fruit juice intake among preschool children not associated with weight
10. Fruit fly study identifies gene mutation that regulates sensitivity to alcohol
11. Fruit fly aggression studies have relevance to humans, animals

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... , ... July 21, 2020 , ... ... transformation and innovation in technology and compliance, announces a new solution to manage ... must ensure every layer of their technology stack complies with FDA and global ...
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced ... will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional ... Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, ...
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a global ... of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of ... located in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible clinical ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... ... True Terpenes , the leading platform for terpene innovation, research and ... the medical potential of terpenes and the potential entourage effect , where the ... focused on expanding the recently launched line of effects-based terpenes - Terpology by ...
(Date:8/12/2020)... , ... August 11, 2020 , ... ... year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network ... and 2022. The network is a consortium of academic research centers in the ...
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... Jim Corrigan, President and CEO has been named one of the 100 most ... industry sectors, PharmaVoice 100 honorees are selected based on how they have inspired ...
Breaking Biology Technology:
Cached News: